• Source: GSK-4112

GSK-4112 is an experimental drug that was developed by GlaxoSmithKline as an agonist of Rev-ErbAα. It is used for studying regulation of the circadian rhythm and its influence on diverse processes such as adipogenesis, regulation of bone density, and inflammation.




See also


SR8278
SR9009
SR9011




References

Kata Kunci Pencarian:

• GSK-4112
• SR9011
• Nidufexor
• MAP1B